- Home
- CDLR vs AGIO Comparison
CDLR vs AGIO Comparison
Compare CDLR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- AGIO
- Stock Information
- Founded
- CDLR 2008
- AGIO 2007
- Country
- CDLR Denmark
- AGIO United States
- Employees
- CDLR N/A
- AGIO N/A
- Industry
- CDLR
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- CDLR
- AGIO Health Care
- Exchange
- CDLR Nasdaq
- AGIO Nasdaq
- Market Cap
- CDLR 2.3B
- AGIO 2.6B
- IPO Year
- CDLR N/A
- AGIO 2013
- Fundamental
- Price
- CDLR $24.05
- AGIO $53.78
- Analyst Decision
- CDLR Strong Buy
- AGIO Buy
- Analyst Count
- CDLR 1
- AGIO 7
- Target Price
- CDLR $37.00
- AGIO $52.33
- AVG Volume (30 Days)
- CDLR 36.7K
- AGIO 726.1K
- Earning Date
- CDLR 11-26-2024
- AGIO 10-31-2024
- Dividend Yield
- CDLR N/A
- AGIO N/A
- EPS Growth
- CDLR N/A
- AGIO N/A
- EPS
- CDLR N/A
- AGIO 11.80
- Revenue
- CDLR $131,862,209.00
- AGIO $32,871,000.00
- Revenue This Year
- CDLR $125.25
- AGIO $33.38
- Revenue Next Year
- CDLR $107.09
- AGIO $163.06
- P/E Ratio
- CDLR N/A
- AGIO $4.56
- Revenue Growth
- CDLR N/A
- AGIO 36.79
- 52 Week Low
- CDLR $16.29
- AGIO $20.96
- 52 Week High
- CDLR $28.75
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- CDLR 31.49
- AGIO 59.21
- Support Level
- CDLR $23.77
- AGIO $43.25
- Resistance Level
- CDLR $25.95
- AGIO $62.58
- Average True Range (ATR)
- CDLR 0.42
- AGIO 2.73
- MACD
- CDLR -0.28
- AGIO 0.71
- Stochastic Oscillator
- CDLR 7.87
- AGIO 54.47
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning, and provides marine and engineering operations to the wind industry with a focus on safety and the environment. The company operates four offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.